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Abstract
Genetic variants in the CARD9 gene predispose to inflammatory disorders and chronic
infectious diseases. Tuberculosis (TB), a chronic infectious disease affecting the lung, is
lethal in Card9-deficient mice. We hypothesized that polymorphisms in the CARD9 gene
influence TB progression and disease-associated lung damage in humans. We tested
genotype distributions of the CARD9 polymorphisms rs4077515, rs10781499 and
rs10870077 in TB patients and healthy subjects in a Caucasian cohort. SNPs were in link-
age disequilibrium and none of the haplotypes was significantly enriched in the TB group.
We determined total and differential leukocyte count, erythrocyte sedimentation rate and
plasma abundance of cytokines and chemokines as markers for systemic inflammation and
scored chest X-rays to assess lung involvement in TB subjects. Most disease parameters
segregated independently of the CARD9 haplotypes. In contrast to multifactorial chronic
inflammation, selected genetic variants in the CARD9 gene leave host responses appar-
ently unaffected in TB, at least in the population analyzed here.
Introduction
Caspase recruitment domain-containing protein 9 (CARD9) is a cytosolic adaptor abundant in
myeloid cells which is essential for recognition of microbes [1, 2]. In experimental animals
CARD9 protects against infectionwith the opportunistic fungusCandida albicans [1] and
intracellular bacteria, such as Listeria monocytogenes [3], and is essential for control of tubercu-
losis (TB)[4]. During infection with the etiological agent of TB,Mycobacterium tuberculosis
(Mtb), the adaptor integrates signals from various pattern recognition receptors [4, 5] and fine-
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tunes concentrations of pro-inflammatory (TNF-α; IL-6; IL-1) and regulatory (IL-10) cyto-
kines. In line with its general propensity to regulate abundance of various TNF and IL-1 family
members [6, 7], selectedCARD9 gene polymorphisms predispose to inflammatory diseases in
humans [8–10]. Polymorphisms in CARD9 have thus far not been studied in the context of
human TB, a contagious disease causing extensive morbidity and mortality worldwide [11],
with complex genetic components [12]. We investigated severalCARD9 single nucleotide poly-
morphisms (SNPs) and defined how this candidate gene influences infection phenotypes, nota-




NCBI SNP database was used to select the CARD9 SNPs previously associated with chronic
inflammation (rs4077515 [9, 10, 13, 14]; rs10870077 [15, 16]; rs10781499 [15, 17, 18]).
rs4077515, a nonsynonymous SNP located in codon 2 of CARD9 gene, leads to an amino acid
substitution at position 12 (p.Ser12Asn) and appears”benign” for protein function [19]. The
rs10781499 is a synonymous SNP located in the third exon of the gene with undefined func-
tional effects [20], while rs10870077 is an intronic variant that might modifyCARD9 expres-
sion [16]. DNA was isolated and purified from blood samples collected on EDTA from 716
Caucasian subjects (342 patients diagnosedwith active pulmonary TB and 374 healthy con-
trols). The Ethics Committee of University of Medicine and Pharmacy of Craiova, Romania,
approved this study (Ethical approval No.03/07.02.2011) and all subjects provided written
informed consent. All subjects were HIV- and type II diabetes-negative. Clinical characteristics
of subjects included in the study, both TB and healthy controls, are presented in Table 1.
Demographic data, total and differential leukocyte counts, erythrocyte sedimentation rate
(ESR) and body-mass index (BMI) were recorded at TB diagnosis, prior to initiation of the che-
motherapy. The algorithm employed to establish the TB diagnosis followed the recommenda-
tions of theWHO [21]. Patients with clinical signs indicative of active disease, TB suggestive
chest radiographic findings and Mtb-positive sputum samples were classified as TB cases.
Genomic DNA was prepared from peripheral blood leukocytes according to the standard
protocol of Wizard1 Genomic DNA PurificationKit (Promega,Madison,WI). Genotyping
for the CARD9 polymorphisms was performedwith the predesigned TaqMan single nucleotide
assays (C_25956930_20, C_32127979_20 and C_25957125_10) on the ViiA7 Real-Time Poly-
merase Chain Reaction system (all from Applied Biosystems, Foster City, CA).
Plasma cytokine and chemokine measurements
Cytokine and chemokine concentrations were measured in all available plasma samples. Speci-
mens were collected prior to chemotherapy against TB, upon confirmation of active disease.
Abundances of immune mediators were determine by multiplex magnetic bead immunoassay
(Luminex assay, R&D Systems), with a Bio Plex microbead analyzer (Bio-Plex1 200 Systems,
Bio-Rad Laboratories, Inc.) according to the manufacturer’s protocol.
Statistical analyses
Statistical analyses were performedwith the R programming language, version 3.1.1. Associa-
tion between haplotypes and disease status (TB vs. non TB) was tested using Fisher's exact test.
For machine learning, we used the random forest algorithm as implemented in the randomFor-
est R package [22]. Associations between haplotypes and continuous variables (quantitative
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locus trait analysis) were tested using analysis of variance. Binomial logistic regression was
used to test the effect of continuous variables on categorical outcomes (BMI and age as predic-
tors for the TB vs. control outcome). Local linear polynomial regression was performed using
the loess function in R. PCA was performedwith the prcomp function in R and visualizedwith
the pca3d package [23]. Multiple correspondence analysis for calculation of the disease severity
score was carried out with themca function from the MASS R package [24]. For post-hoc
ANOVA tests, the Tukey Honest SignificanceDifferences test was used.
Results and Discussion
Recent genome-wide association studies and meta-analyses indicate that selectedCARD9 SNPs
result in predisposition to chronic inflammatory disorders [8–10, 25]. Based on our previous
study in murine TB [4] and considering that TB is characterized by non-resolved inflamma-
tion, we hypothesized that similar genetic variants could influence progression of latent to
active TB. To test our hypothesis, genotype distributions of three CARD9 polymorphisms,
-201C/T (rs4077515), -311G/C (rs10870077), and -126C/T (rs10781499) were tested in a Cau-
casian cohort of Romanian ethnicity. Vaccination is mandatory in this TB-endemic region and
thus we anticipated that subjects enrolled in our study had been immunized as infants with the
vaccineM. bovis Bacille Calmette-Guérin (BCG). The analyzed SNPs showed linkage disequi-
librium and haplotypes were equally distributed in both TB and healthy groups (Table 2). Our
findings are in line with reports nullifying a link betweenCARD9 rs4077515 genotypes and sus-
ceptibility to candidemia and recurrent vulvovaginal candidiasis [13, 19]. However, a lack of
association betweenCARD9 variants and active TB diverges from associations reported for sev-
eral chronic inflammatory diseases, including Crohn’s disease [8, 10, 16] and ankylosing spon-
dylitis [15]. Despite the chronic feature of adult pulmonary TB, preexisting anti-mycobacterial
immunity in the population studied couldmask effects of CARD9 polymorphisms on TB
progression.
Table 1. Demographic and clinical features of study subjects.
Group Gender ratio (F/M) Age (y) BMI WBC count (cells/mm3) Neutrophil count (cells/mm3) Baseline ESR
Active TB (n = 342) 62 / 280 50.23±14.05 21.20±3.99 8.84±3.46 6.2±3.29 45±43.72
Healthy controls (n = 374) 156 / 218 59.38±13.82 25.11±4.6 6.8±1.85 4.43±1.5 30±22.03
BMI, Body mass index; WBC, White blood cell; ESR, Erythrocyte sedimentation rate. Values are mean±SD.
doi:10.1371/journal.pone.0163662.t001
Table 2. CARD9 rs4077515, rs10870077, rs10781499 major haplotypes in active TB patients and
healthy controls.
Haplotype Group







p-value (Fisher’s Test) = 0.3671.
doi:10.1371/journal.pone.0163662.t002
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We further investigated whether distinctCARD9 variants influence inflammatory responses
in active TB. Plasma abundances of TB-relevant cytokines and chemokines were determined in
a sub-cohort of TB cases. Individuals carrying the TT.GG.AA haplotype produced significantly
lower levels of IFN-ɣ, CCL3, and CCL5 compared with the other two major haplotypes (Fig 1).
IFN-ɣ is critical for defense against TB [26], yet high concentrations could indicate more severe
pathology [27]. Because the CC chemokines orchestrate the dynamics of leukocytes, and
reduced abundance reflects limited inflammation, we therefore expected an effect of the geno-
types on clinical manifestation of TB. This presumption was not supported by principal com-
ponent analysis (PCA) integrating clinical covariates (Fig 2). The clinical covariates included
BMI and parameters allowing evaluation of emergency hematopoiesis, such as whole blood cell
(WBC) counts and frequencies of neutrophils and lymphocytes, as well as ESR, a marker of sys-
temic inflammation. No correlation between the major CARD9 haplotypes and principal com-
ponents was observed, thus revealing similar systemic inflammation irrespective of the gene
variant. These findings could be due to variable expression of the CARD9 gene in distinct hap-
lotypes. Alternatively, tested SNPs regulate expression quantitative trait loci (eQTL) in trans. A
cis eQTL effect of the tested SNPs is unlikely, as genes neighboringCARD9 are not directly
associated with immune functions.
In order to assess how distinctCARD9 SNPs affect disease severity we first elaborated a
severity score (RS1). RS1 served as a disease proxy (Fig 3A) and was built on sputum microbi-
ology and chest X-ray scores (Table 3). RS1 showed a direct correlation with leukocyte count,
includingWB and neutrophil counts, and ESR values, and furthermore it was inversely corre-
lated with the BMI (Fig 3B). Indeed, neutrophilia represents a marker of poor prognosis in TB
patients [28] and heightened neutrophil frequencies correlate with severity of pulmonary TB
[29]. These observations support our newly defined disease proxy parameter. However,
patients carrying various CARD9 haplotypes presented similar disease severity scores (Fig 3C).
AlthoughCard9mutant mice [4] develop severe inflammation during TB, in the case of
humans, inflammatorymediators and disease severity did not differ profoundly in patients car-
rying distinctCARD9 variants. The disparity betweenmouse and man is unlikely to rely on the
variability of outcomes measured. In both mice and humans we measured several inflamma-
tory parameters to monitor systemic (sera/plasma levels of cytokines) and lung inflammation.
Indeed, in humans we employed RS1 to overcome inaccessibility of the lung tissue and assess
the lung involvement whereas in mice we evaluated lung changes by histopathologic examina-
tion of the tissue. RS1 was built on lung radiographic changes, correlated very well with sys-
temic inflammationmarkers, which increase upon exacerbated lung damage [29], and thus
emerged as a valuable surrogate of pathology, as used in mice.
The phenotype reported in mice largely relies on expression of Card9 in neutrophils for IL-
10 release, whereas human neutrophils are unable to produce this regulatory cytokine due to
an inactive chromatin configuration at the IL10 locus [30]. This difference could explain dis-
crepancies observedbetweenmice and humans regarding CARD9 control of inflammation.
Moreover, the observeddiscrepancy betweenCard9 knock-outmice and severity of TB in
humans can rely on loss-of-function in the murine system, while in humans the SNPs could
result in lower abundance of or modifications in the CARD9 protein structure leading to sig-
naling defects.We did not determine the expression level of the CARD9 gene or abundances of
the encoded protein in blood specimens of variable haplotypes. Of note, the CARD9 gene is
under significant cis regulation [15] and presumably single SNPs minimally affect protein
structure.
In this study we provide evidence that CARD9 genetic variants in rs4077515, rs10781499
and rs10870077 do not affect progression to active TB in a cohort from a TB-endemic region
with an ongoing BCG vaccination program. In mice, vaccination has been found to protect the
Tuberculosis Is Uncoupled from CARD9 Polymorphisms
PLOS ONE | DOI:10.1371/journal.pone.0163662 September 29, 2016 4 / 10
Tuberculosis Is Uncoupled from CARD9 Polymorphisms
PLOS ONE | DOI:10.1371/journal.pone.0163662 September 29, 2016 5 / 10
Card9-deficient animals against lethality due to TB [4]. Genetic studies in BCG-naive humans
are required before conclusions can bemade on the development of active TB, irrespective of
the CARD9 haplotypes. Moreover, our study was undertaken in a single cohort. Investigations
in additional populations and larger cohorts will need to overcome such limitations. We have
guided our study by reports centered on chronic inflammation, and tested selected SNPs. As
the effects of additional CARD9 SNPs on progression to active TB cannot be excluded, a fine-
mapping of the CARD9 gene could help elucidate whether other gene variants imprint on sus-
ceptibility to TB in humans.
Fig 1. CARD9 genetic variants affect abundances of selected chemokines and cytokines in active
TB. Abundances (pg/ml) of selected soluble immune mediators for the three major haplotypes (rs4077515,
rs10870077, rs10781499) analyzed. Each point corresponds to a single sample. Horizontal bars show the p-
value in post-hoc Tukey Honest Significance Differences test, calculated after an initial ANOVA on log-
transformed data.
doi:10.1371/journal.pone.0163662.g001
Fig 2. Association between CARD9 haplotypes and clinical parameters in TB patients. PCA of samples from TB patients applied
to clinical covariates (age, BMI, WBC, neutrophils, lymphocytes and ESR) and colored by haplotype.
doi:10.1371/journal.pone.0163662.g002
Tuberculosis Is Uncoupled from CARD9 Polymorphisms
PLOS ONE | DOI:10.1371/journal.pone.0163662 September 29, 2016 6 / 10
While the selectedCARD9 SNPs predispose to chronic inflammation in multifactorial
inflammatory diseases [10, 14, 25, 31], their roles in human infections driven by specific
microbes, such as Mtb, as shown here, and Candida spp. [13, 19], appears limited. Nonetheless,
more than 15 missense and nonsense CARD9 point mutations (Q295X; Q289X; R70W; R35Q
or R101L are some of the rare variants identified) have been associated with development of
fungal diseases [32–36]. Such mutations result either in synthesis of a nonfunctional protein or
lack of the CARD9 protein. In contrast to loss-of-functionmutations, CARD9 SNPs including
rs4077515, leave cytokine production unchanged in leukocytes stimulated with fungi. The SNP
thus minimally affects the function of the adaptor protein and is uncoupled from susceptibility
to candidemia [19]. Unlike previous reports in inflammatory polyfactorial diseases, selected
SNPs do not affect the course of TB or fungal infection. Additional studies investigating sup-
plementaryCARD9 SNPs and effects of CARD9 variants in unrelated infections will permit
Fig 3. Severity of pulmonary TB is not linked to CARD9 haplotypes. (a) Disease severity score RS1 calculated using multifactor correspondence
analysis (MCA) based on the clinical scores obtained from parameters monitored during sputum microscopy and chest X-ray; (b) Local polynomial
regression on four clinical covariates (BMI, WBC, neutrophils and ESR) and severity score RS1 derived from MCA for samples from TB patients. Each point
corresponds to a single sample. Light colored area, 95% prediction confidence interval; dark colored area, 95% estimation confidence interval; (c) TB
severity score among patients carrying various CARD9 haplotypes.
doi:10.1371/journal.pone.0163662.g003
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insights into divergent roles of this adaptor molecule in chronic inflammation of microbial and
non-microbial origin.
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